Fesobig 4gm tablet is an antimuscarinic agent that contains an active ingredient called Fesoterodine fumarate. This medicine treats symptoms associated with an overactive bladder, such as urgency incontinence (inability to control bladder emptying), sudden urination urges, and increased urinary frequency. This medicine is not advised to use in children under 18 years old. Notify your doctor if you are intolerant to lactose and fructose.

Fesobig 4gm tablet should not be taken if you have allergies to Fesoterodine or Fructose, inability to empty your bladder (urinary retention), slow stomach emptying (gastric retention), narrow-angle glaucoma, excessive muscle weakness, severe ulcerative colitis, abnormally large colon. It is not advised to consume this medicine if you are taking specific medications for HIV, depression, and fungal or bacterial infections. Don't consume this medicine if you are pregnant or planning to get pregnant or breastfeeding. 

Before taking Fesobig 4gm tablet, it is important to consult with your doctor if you have difficulty emptying your bladder, decreased bowel movements or severe constipation, narrow-angle glaucoma, serious kidney or liver problems, autonomic neuropathy, a gastrointestinal disease affecting food passage or digestion, heartburn, belching, or urinary tract infection. Your doctor may adjust your dose or prescribe additional medications based on your situation. Before taking Fesobig 4gm tablet, Notify your doctor if you have any heart conditions such as abnormal ECG (QT prolongation) or taking medications that may cause it, slow heart rate (bradycardia), myocardial ischemia, irregular heartbeat, heart failure, hypokalemia (low potassium levels in the blood).

• Treatment of overactive bladder (OAB) symptoms.
• Helps to control uncontrollable bladder emptying (urgency incontinence).
• Reduces sudden urges to urinate.
• Reduces frequent urination.

Fesobig 4gm tablet belongs to a group of medications known as antimuscarinics. Its mechanism of action involves relaxing the bladder muscles to prevent involuntary and frequent urination. This helps alleviate symptoms of urgency, frequency, and uncontrolled urination.

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Fesobig 4gm tablet and can cause undesirable side effects.

• Keep out of sight and reach of pets and children.
• Do not freeze the medicine.
• Do not store above 25°C.
• Always check the expiry date before consuming it.

Take the Fesobig 4gm tablet as your physician advises. Usually, the tablets will be taken with or without food. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious

• Angioedema ( swelling of the face, mouth, or throat)

Common

• Difficulty in sleeping
• Dry eyes, throat
• Dizziness
• Dysuria (painful or difficult urination)
• Constipation
• Drowsiness
• Nausea

Liver, heart, and kidney patients should take Fesobig 4gm tablet cautiously and inform their doctor about all the underlying medical conditions. Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Do not breastfeed while taking this medicine unless your doctor advises. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information.

1. Laboratorios Normon, S.A., Electronic Medicines Compendium (EMC), [Revised on February 2022] [Accessed on 5th June 2023], *Microsoft Word - PL-Fesoterodine-clean (medicines.org.uk)
2. Pfizer, US Food and Drug Administration; [Revised on April 2008] [Accessed on 5th June 2023], label (fda.gov)